Skip to main content

Wolters Kluwer introduces Ovid Synthesis Expert AI, with breakthrough capabilities that accelerate mission critical healthcare improvement initiatives

Expert AI-powered enhancements offer real-time support to boost quality improvement, evidence-based practice, and research project output

Wolters Kluwer Health today announced the launch of new AI features in Ovid® Synthesis to further support nursing and quality improvement leaders, practitioners and researchers in elevating the quality, speed, and impact of their improvement work. Created with feedback from customers and industry experts and now available as an optional add-on to the Ovid Synthesis platform, Ovid Synthesis Expert AI helps organizations accelerate evidence-based practice (EBP), quality improvement (QI), and research projects by streamlining manual and rigorous project tasks.

“Healthcare systems are under immense pressure to deliver measurable improvements with fewer resources, and that requires smarter, faster ways of working,” said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. “Ovid Synthesis Expert AI is designed to eliminate the friction points that slow down improvement initiatives—like manual literature reviews, inconsistent mentorship, and fragmented workflows. By embedding Expert AI directly into the process, we’re enabling teams to accelerate progress, scale their impact, and uphold the highest standards of clinical and academic excellence.”

Ovid Synthesis Expert AI reallocates more time for patient care

Ovid Synthesis Expert AI addresses three critical barriers to completing improvement projects rapidly, including reducing the time-consuming critical appraisal process, solving for the delayed feedback from overburdened mentors, and transforming the otherwise manual research dissemination. Ovid Synthesis Expert AI empowers clinicians and educators to scale their initiative impact—regardless of experience or location. The following functionality frees up time to focus on strategic initiatives and patient-centered care, by supporting:

  • Critical Appraisal: AI-generated summaries with sources for each element of a critical appraisal form allows teams to more quickly assess literature while ensuring quality by easily reviewing the sources within the article that were used in the summaries.
  • Clinical Question Feedback: AI provides teams with real-time guidance and suggestions for refining their PICO(T) questions. This helps keep teams motivated and reduces mentorship load, ensuring projects are clear and well defined.
  • Dissemination: AI converts project results into several draft formats for rapid internal and external dissemination including conference abstracts, manuscript drafts, and newsletter content.

"Artificial intelligence, through tools like Ovid Synthesis Expert AI, accelerates evidence-based practice, quality improvement, and research by streamlining the search, critiquing the evidence, and translating hours of work into minutes of insight—giving nurses more time where it matters most: at the bedside,” said Una T. Hopkins, DNP, RN, FNP-BC, NE-BC, FACCC, Director of Nursing Research at Montefiore Einstein Medical Center and President of the Association of Cancer Care Centers.

Clinicians and medical librarians leverage AI to support workflows

The Ovid Synthesis platform was built to improve clinician job satisfaction and drive better patient outcomes by streamlining workflows, providing easier access to reliable evidence, and fostering collaboration among team members. Healthcare leaders trust the platform to evaluate the ROI of improvement initiatives, helping them demonstrate the value and ongoing investment for evidence-based practice.

The developments of Ovid Synthesis Expert AI were supported by collaborators in the field, as medical librarians and clinicians helped identify and verify the most pressing challenges they encountered when working on EBP, QI and research projects. Through this process, Wolters Kluwer purpose-built a solution utilizing its Expert AI technology to improve workforce efficiency and maintain academic rigor. By addressing variability in research proficiency and reducing barriers to scholarly writing and dissemination, the platform has emerged as a strategic enabler of organizational learning and quality advancement, supporting both project-level execution and broader institutional goals for clinical inquiry, innovation, and improvement.

Ovid Synthesis Expert AI is enabled by Wolters Kluwer Expert AI. Solutions built on Wolters Kluwer Expert AI use deep domain expertise and a decade of AI experience, empowering customers to work faster and make smarter decisions based on trusted and verified content.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

Ovid Synthesis Expert AI launches to accelerate evidence-based practice, quality improvement, and research projects.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.69
+0.72 (0.32%)
AAPL  268.41
-0.40 (-0.15%)
AMD  260.26
+0.59 (0.23%)
BAC  52.85
-0.17 (-0.31%)
GOOG  268.00
-1.93 (-0.72%)
META  752.60
+1.78 (0.24%)
MSFT  542.96
+11.44 (2.15%)
NVDA  192.73
+1.24 (0.65%)
ORCL  281.92
+0.52 (0.18%)
TSLA  461.44
+9.01 (1.99%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.